| ［1］ Subbarao K, Klimov A, Katz J, et al. Characterization of an Avian influenza A(H5N1) Virus isolated from a child with a fetal respiratory illness. Science, 1998,279(16):393～396
［2］ Zhu Q Y, Qin E D, Wang W, et al. Fatal infection with influenza A (H5N1) virus in china. N Engl J Med, 2006,354(25):2731～2732
［3］ Li K S, Guan Y, Wang J, et al. Genesis of highly pathogenic and potentially pandemic H5N1 influenza virus in eastern Asia. Nature, 2004,430:209～213
［4］ Colman P M. Influenza virus neuraminidase: structure, antibodies, and inhibitors. Protein Science, 1994,3:1687～1689
［5］ Ohuchi M, Asaoka N, Sakai T, et al. Roles of neuraminidase in the initial stage of influenza virus infection. Microbes and Infection, 2006,8:1287～1293
［6］ Hata K, Koseki K, Yamaguchi K, et al. Limited inhibitory effects of oseltamivir and zanamivir on human sialidases. Antimicrob Agents CH,2008,52(10):3484～3491
［7］ Marija L, Petar M. Another look at the molecular mechanism of the resistance of H5N1 influenza A virus neuraminidase (NA) to oseltamivir (OTV). Biophysical Chemistry, 2008,136:152～158
［8］ Robert W, Donald F. In vitro and in viro assay systems for study of influenza virus inhibitors. Antiviral Research, 2000,48:1～16
［9］ 刘艾林,曹鸿鹏,杜冠华.流感病毒神经氨酸酶抑制剂的筛选.中国科学C辑：生命科学,2005,35(1)：2～5
Liu A L, Cao H P, Du G H. Science in china ser C life sciences, 2005,35(1): 2～5
［10］ Lackenby A, Democratis J, Siqueira M M, et al. Rapid quantitation of neuraminidase inhibitor drug resistance in influenza virus quasispecies. Antiviral Therapy, 2008,13(6):809～820
［11］ 卢希彬,戴平,郭玉函.密码子偏爱性与外源蛋白的表达.中国生物工程杂志，2006，26(0)：170～172
Lu X B, Dai P, Gu Y H. China Biotechnology, 2006, 26(0):170～172
［12］ Su C Y, Wang S Y, Shie J J, et al. In vitro evaluation of neuraminidase inhibitors using the neuraminidasedependent release assay of hemagglutininpseudotyped viruses. Antiviral Research, 2008,79(3):199～205
［13］ Plakokefalos E T, Markoulatos P, Spyrou N, et al. Molecular and phylogenetic ananlysis of haemagglutinin and neuraminidase sequences from recent human influenza type A(H3N2) viral isolates in Southern Greece. Arch Virol, 2001, 146(10):1899～1918
［14］ Neumann G, Fujii K, Kino Y, et al. An improved reverse genetics system for influenza A virus genetation and its implications for vaccine production. PNAS, 2005, 102(46):16825～16829
［15］ Morris S J, Nightingale K, Smith H, et al. Influenza A virusinduced apotosis is a multifactorial process: Exploiting reverse genetics to elucidate the role of influenza A virus proteins in virusinduced apoptosis. Virology, 2005, 335(2):198～211
［16］ Wang M Z, Tai C T, Mendel D B. Mechanism by which mutations at His274 alter sensitivity of influenza A virus N1 neuraminidase to oseltamivir carboxylate and zanamivir. Antimicrobial Agents and Chemotherapy, 2002, 46(12):3809～3816
［17］ 高雷, 章天, 陈鸿珊. 黄芩甙对流感病毒神经氨酸酶的抑制作用. 临床研究，2007,45（18）: 84～85
Gao L, Zhang T, Chen H P. China Modern Doctor, 2007,45(18):84～85 |
